RENATO FRAGA RIGHETTI
Projetos de Pesquisa
Unidades Organizacionais
LIM/20 - Laboratório de Terapêutica Experimental, Hospital das Clínicas, Faculdade de Medicina
3 resultados
Resultados de Busca
Agora exibindo 1 - 3 de 3
- Specific NFKappaB and Rho-Quinase inhibitors compared to corticosteroid in asthma model in mice(2017) SOUZA, Flavia; CAMARGO, Leandro; RIGHETTI, Renato; ARISTOTELES, Luciana; MARUYAMA, Tabata; FUKUZAKI, Silvia; LEICK, Edna; MARTINS, Milton; PRADO, Carla; TIBERIO, Iolanda; ROMANHOLO, Beatriz
- Effects of anti-IL17 on acute lung injury induced by LPS in mice(2017) RIGHETTI, Renato; SANTOS, Tabata Maruyama dos; CAMARGO, Leandro do Nascimento; ARISTOTELES, Luciana Ritha de Cassia Rolim Barbosa; FUKUZAKI, Silvia; SOUZA, Flavia Castro Ribas de; CRUZ, Maysa Mariana; ALONSO-VALE, Maria Isabel Cardoso; SARAIVA-ROMANHOLO, Beatriz Mangueira; LEICK, Edna Aparecida; MARTINS, Milton de Arruda; PRADO, Carla Maximo; TIBERIO, Iolanda de Fatima Lopes Calvo
- A Plant Proteinase Inhibitor from Enterolobium contortisiliquum Attenuates Pulmonary Mechanics, Inflammation and Remodeling Induced by Elastase in Mice(2017) THEODORO-JUNIOR, Osmar Aparecido; RIGHETTI, Renato Fraga; ALMEIDA-REIS, Rafael; MARTINS-OLIVEIRA, Bruno Tadeu; OLIVA, Leandro Vilela; PRADO, Carla Maximo; SARAIVA-ROMANHOLO, Beatriz Mangueira; LEICK, Edna Aparecida; PINHEIRO, Nathalia Montouro; LOBO, Yara Aparecida; MARTINS, Milton de Arruda; OLIVA, Maria Luiza Vilela; TIBERIO, Iolanda de Fatima Lopes CalvoProteinase inhibitors have been associated with anti-inflammatory and antioxidant activities and may represent a potential therapeutic treatment for emphysema. Our aim was to evaluate the effects of a plant Kunitz proteinase inhibitor, Enterolobium contortisiliquum trypsin inhibitor (EcTI), on several aspects of experimental elastase-induced pulmonary inflammation in mice. C57/Bl6 mice were intratracheally administered elastase (ELA) or saline (SAL) and were treated intraperitoneally with EcTI (ELA-EcTI, SAL-EcTI) on days 1, 14 and 21. On day 28, pulmonary mechanics, exhaled nitric oxide (ENO) and number leucocytes in the bronchoalveolar lavage fluid (BALF) were evaluated. Subsequently, lung immunohistochemical staining was submitted to morphometry. EcTI treatment reduced responses of the mechanical respiratory system, number of cells in the BALF, and reduced tumor necrosis factor- (TNF-), matrix metalloproteinase-9 (MMP-9), matrix metalloproteinase-12 (MMP-12), tissue inhibitor of matrix metalloproteinase (TIMP-1), endothelial nitric oxide synthase (eNOS) and inducible nitric oxide synthase (iNOS)-positive cells and volume proportion of isoprostane, collagen and elastic fibers in the airways and alveolar walls compared with the ELA group. EcTI treatment reduced elastase induced pulmonary inflammation, remodeling, oxidative stress and mechanical alterations, suggesting that this inhibitor may be a potential therapeutic tool for chronic obstructive pulmonary disease (COPD) management.